Artificial Intelligence To Improve Breast Cancer Patient Outcomes
Monday, September 28, 2015 - 08:40
in Health & Medicine
Western University researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy medications used to treat breast cancer - paclitaxel and gemcitabine. Peter Rogan, PhD, and a team of researchers, including Stephanie Dorman, PhD, and Katherina Baranova, BMSc, at Western's Schulich School of Medicine&Dentistry, are hoping to one day remove the guesswork from breast cancer treatment with this technique. Based on personal genetic analysis of their tumours, patients with the same type of cancer can have different responses to the same medication. While some patients will respond well and go into remission, others will develop a resistance to the medication. read more